Geode Capital Management’s iTeos Therapeutics ITOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.02M | Buy |
703,467
+53,414
| +8% | +$533K | ﹤0.01% | 2557 |
|
|
2025
Q1 | $3.88M | Buy |
650,053
+5,152
| +0.8% | +$30.8K | ﹤0.01% | 2768 |
|
|
2024
Q4 | $4.95M | Buy |
644,901
+4,551
| +0.7% | +$35K | ﹤0.01% | 2754 |
|
|
2024
Q3 | $6.54M | Buy |
640,350
+20,092
| +3% | +$205K | ﹤0.01% | 2613 |
|
|
2024
Q2 | $9.21M | Buy |
620,258
+36,738
| +6% | +$545K | ﹤0.01% | 2372 |
|
|
2024
Q1 | $7.96M | Buy |
583,520
+14,660
| +3% | +$200K | ﹤0.01% | 2458 |
|
|
2023
Q4 | $6.23M | Buy |
568,860
+36,773
| +7% | +$403K | ﹤0.01% | 2591 |
|
|
2023
Q3 | $5.83M | Buy |
532,087
+30,075
| +6% | +$329K | ﹤0.01% | 2569 |
|
|
2023
Q2 | $6.65M | Buy |
502,012
+20,773
| +4% | +$275K | ﹤0.01% | 2541 |
|
|
2023
Q1 | $6.55M | Buy |
481,239
+9,731
| +2% | +$132K | ﹤0.01% | 2505 |
|
|
2022
Q4 | $9.21M | Buy |
471,508
+24,627
| +6% | +$481K | ﹤0.01% | 2319 |
|
|
2022
Q3 | $8.51M | Buy |
446,881
+48,806
| +12% | +$930K | ﹤0.01% | 2357 |
|
|
2022
Q2 | $8.2M | Sell |
398,075
-1,375
| -0.3% | -$28.3K | ﹤0.01% | 2395 |
|
|
2022
Q1 | $12.9M | Buy |
399,450
+25,662
| +7% | +$826K | ﹤0.01% | 2176 |
|
|
2021
Q4 | $17.4M | Buy |
373,788
+26,425
| +8% | +$1.23M | ﹤0.01% | 2049 |
|
|
2021
Q3 | $9.38M | Buy |
347,363
+63,385
| +22% | +$1.71M | ﹤0.01% | 2493 |
|
|
2021
Q2 | $7.28M | Buy |
283,978
+8,569
| +3% | +$220K | ﹤0.01% | 2682 |
|
|
2021
Q1 | $9.41M | Buy |
275,409
+94,297
| +52% | +$3.22M | ﹤0.01% | 2402 |
|
|
2020
Q4 | $6.13M | Buy |
181,112
+30,816
| +21% | +$1.04M | ﹤0.01% | 2492 |
|
|
2020
Q3 | $3.71M | Buy |
+150,296
| New | +$3.71M | ﹤0.01% | 2564 |
|